Home/Filings/4/0001140361-10-049584
4//SEC Filing

Caldwell William S 4

Accession 0001140361-10-049584

CIK 0001124105other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 5:24 PM ET

Size

9.1 KB

Accession

0001140361-10-049584

Insider Transaction Report

Form 4
Period: 2010-12-13
Caldwell William S
VP - Drug Discovery and Dev.
Transactions
  • Exercise/Conversion

    Common Stock

    2010-12-13$1.75/sh+12,000$21,00019,735 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2010-12-1312,0000 total
    Exercise: $1.75Exp: 2015-03-28Common Stock (12,000 underlying)
  • Sale

    Common Stock

    2010-12-13$23.95/sh12,000$287,3777,735 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.76 to $24.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]This option vested in installments and became vested and exercisable in full on December 31, 2008.

Documents

1 file

Issuer

TARGACEPT INC

CIK 0001124105

Entity typeother

Related Parties

1
  • filerCIK 0001295829

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 5:24 PM ET
Size
9.1 KB